نتایج جستجو برای: tp53 protein

تعداد نتایج: 1240012  

Journal: :American journal of clinical pathology 2010
Hong Chang Allan M Jiang Connie X Y Qi

Hemizygous TP53 gene deletion is the most important adverse risk factor in chronic lymphocytic leukemia (CLL), but its relationship with p53 protein expression is unclear. We investigated 110 CLL cases and correlated nuclear p53 protein immunoreactivity with TP53 gene deletion status and other CLL-associated genetic risk factors. Fluorescence in situ hybridization detected hemizygous TP53 delet...

Journal: :Oncology reports 2007
Marcela Aranda Fernando Gonzalez-Nilo Gonzalo Riadi Victor Díaz José Perez Ghyslaine Martel Pierre Hainaut Adriana Mimbacas

The p53 tumor suppressor gene (TP53; OMIM: 191170) plays an important role in tumorigenesis in lung epithelial cells. TP53 encodes a sequence-specific DNA-binding protein that regulates transcription of several genes in response to DNA damage promoting cell cycle arrest, DNA repair or apoptosis. A mutation does not necessarily alter the protein function and since not all altered tumor protein p...

A Vaziri Gohar GH Mohammadi M Baghaie M.R Shakibaie

Introduction: Despite improvements in the diagnosis and treatment of lung cancer in the past two decades, it has remained the most common cause of death from cancer worldwide. Among all genes that are mutated in lung cancer, TP53 located on chromosome 17P13/1 has a significant diagnostic and prognostic value. TP53 mutations have been extensively studied in lung cancer and TP53 mutational spectr...

2015
Chun-Ting Kuo Chieh Chang Wen-Sen Lee

To investigate the molecular mechanism underlying folic acid (FA)-induced anti-colon caner activity, we showed that FA caused G0/G1 arrest in COLO-205. FA activated the proto-oncogene tyrosine-protein kinase Src (c-SRC)-mediated signaling pathway to enhance nuclear factor of kappa light polypeptide gene enhancer in B-cells (NFκB) nuclear translocation and binding onto the tumor protein p53 (TP5...

2014
Thomas Bonacci Sylvain Peuget Philippe Soubeyran Juan Iovanna Nelson J Dusetti

Oxidative stress-induced sumoylation of TP53INP1 (tumor protein p53-induced nuclear protein 1) is essential to enhance the TP53 response. Sumoylation of TP53INP1 on the K113 residue, which is mediated by protein inhibitor of activated STAT 3 (PIAS3) and chromobox homolog 4 (CBX4) and removed by SUMO1/sentrin specific peptidase (SENP1, 2 and 6), favors its interaction with TP53 in the nucleus an...

2013
Federico Pozzo Michele Dal Bo Nadia Peragine Riccardo Bomben Antonella Zucchetto Francesca Maria Rossi Massimo Degan Davide Rossi Annalisa Chiarenza Alberto Grossi Francesco Di Raimondo Francesco Zaja Gabriele Pozzato Paola Secchiero Gianluca Gaidano Giovanni Del Poeta Giorgio Zauli Robin Foà Anna Guarini Valter Gattei

BACKGROUND TP53 defects, i.e., 17p13 deletion and/or nucleotide mutations, associate with short survival and chemorefractoriness in chronic lymphocytic leukemia (CLL). In this context, since direct sequencing of the TP53 gene does not evaluate TP53 functionality, a functional assessment of TP53 pathway may be of interest to identify high risk CLL. By taking advantage of a training cohort of 100...

2015
PAVLA BRACHOVA SAMUEL R. MUETING MATTHEW J. CARLSON MICHAEL J. GOODHEART ANNA M. BUTTON SARAH L. MOTT DONGHAI DAI KRISTINA W. THIEL ERIC J. DEVOR KIMBERLY K. LESLIE

Individual mutations in the tumor suppressor TP53 alter p53 protein function. Some mutations create a non-functional protein, whereas others confer oncogenic activity, which we term 'oncomorphic'. Since mutations in TP53 occur in nearly all ovarian tumors, the objective of this study was to determine the relationship of oncomorphic TP53 mutations with patient outcomes in advanced serous ovarian...

Journal: :International journal of oncology 2007
Birgitte Lid Adamsen Katherine L Kravik Ole P F Clausen Paula M De Angelis

Loss of TP53 function may contribute to 5-fluorouracil (5-FU) resistance in colorectal cancer since TP53-deficient cells may be unable to undergo apoptosis in response to 5-FU-induced DNA damage. 5-FU treatment of TP53-deficient cells would provide useful information on the apoptotic response to drug-induced DNA damage in the absence of TP53 and its transcriptional targets. We investigated apop...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001
S J Klug R Wilmotte C Santos M Almonte R Herrero I Guerrero E Caceres D Peixoto-Guimaraes G Lenoir P Hainaut J M Walboomers N Muñoz

The role of a polymorphism at position 72 of the tumor suppressor gene TP53 in the development of cervical cancer is not well established. The arginine variant of the p53 protein could be more susceptible to degradation by human papillomavirus (HPV) E6 protein than the protein containing proline. Recent studies show controversial results. We investigated a possible association between TP53 poly...

2001
Stefanie J. Klug Rick Wilmotte Carlos Santos Maribel Almonte Rolando Herrero Ivonne Guerrero Eduardo Caceres Denise Peixoto-Guimaraes Gilbert Lenoir Pierre Hainaut Jan M. M. Walboomers Nubia Muñoz

The role of a polymorphism at position 72 of the tumor suppressor gene TP53 in the development of cervical cancer is not well established. The arginine variant of the p53 protein could be more susceptible to degradation by human papillomavirus (HPV) E6 protein than the protein containing proline. Recent studies show controversial results. We investigated a possible association between TP53 poly...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید